Movers & Shakers | GenomeWeb

Movers & Shakers

Premium

Adarza Biosystems this week appointed Heiner Dreismann and James Senall to its board of directors.

Dreismann was previously the CEO of Roche Molecular Systems and held several senior positions at Roche Diagnostics before that.

Senall is the president of High Tech Rochester, an Adarza shareholder, and is director of the Rochester Angel Network. Previously, he was managing director of business development at Greater Rochester Enterprise.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.